Virtu Financial’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-40,655
Closed -$7K 2233
2023
Q2
$7K Buy
40,655
+26,481
+187% +$25.4K ﹤0.01% 1385
2023
Q1
$23K Buy
+14,174
New +$28.8K ﹤0.01% 1226
2022
Q1
Sell
-10,521
Closed -$226K 2442
2021
Q4
$226K Sell
10,521
-721
-6% -$19.3K 0.02% 781
2021
Q3
$368K Buy
+11,242
New +$412K 0.03% 613
2021
Q1
Sell
-2,943
Closed -$193K 2267
2020
Q4
$193K Buy
+2,943
New +$192K 0.02% 874
2020
Q3
Sell
-425
Closed -$41K 1721
2020
Q2
$41K Buy
+425
New +$31.7K ﹤0.01% 1034
2018
Q1
Sell
-1,678
Closed -$206K 2842
2017
Q4
$206K Buy
+1,678
New +$230K 0.01% 1649

Other funds holding SRGA

Virtu Financial's SRGA Position: Q3 2023 in Review

Virtu Financial sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 40,655 shares — an estimated $7K sold.

Virtu Financial first reported a position in SRGA in Q4 2017 and held it in 7 quarters. The position peaked at $368K in Q3 2021. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

  • Virtu Financial reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Virtu Financial sold 40,655 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $7K.
  • Virtu Financial first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2017 and held it in 7 quarters.
  • Virtu Financial's Surgalign Holdings, Inc. Common Stock position peaked at $368K in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.